
NYSE:IBM
This summary was created by AI, based on 25 opinions in the last 12 months.
IBM Common Stock has received mixed reviews from various experts, showcasing a blend of confidence and caution regarding its future. The stock has experienced a significant drop, down 17% this year, yet many analysts see potential growth driven by key sectors like AI and quantum computing. While various analysts recognize the company's considerable investments in hybrid cloud and AI, concerns about its valuation and past performance also emerge. Analysts generally agree that despite some execution slip-ups, IBM maintains strong software capabilities and a promising future, particularly with its $1.3 trillion addressable market in quantum computing by 2030. Overall, while some view IBM as a buying opportunity, others express worries about its competitive position and valuation metrics.
Sentiment is very low and it has underperformed recently. It is not the old hardware business. Mostly it is software and the cloud. They are investing in growth areas. Revenues are starting to grow again. He thinks there will be a significant rerating of the stock. The PE is only 10 times. (Analysts’ target: $166.67).
This has struggled in terms of growing their top line. Warren Buffett had a big position and has since trimmed it. This might have been a bit of an ROE trap. They might have been slow to adjust to the new technological landscape. It has gone basically nowhere over the last 10 years. There are a lot better opportunities in the Tech space.
She has not held this name, because it got so large it couldn't really grow its top line anymore. They managed to grow the bottom line by buying back stock. There is not a lot of growth in this. They’re trying to change that through acquisitions, and that will take some time. You typically buy technology stocks for growth, and she feels there are more attractive growth companies than this one.